BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30018301)

  • 1. A monocyte gene expression signature in the early clinical course of Parkinson's disease.
    Schlachetzki JCM; Prots I; Tao J; Chun HB; Saijo K; Gosselin D; Winner B; Glass CK; Winkler J
    Sci Rep; 2018 Jul; 8(1):10757. PubMed ID: 30018301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of mitochondrial and proteolysosomal genes in Parkinson's disease myeloid cells.
    Navarro E; Udine E; de Paiva Lopes K; Parks M; Riboldi G; Schilder BM; Humphrey J; Snijders GJL; Vialle RA; Zhuang M; Sikder T; Argyrou C; Allan A; Chao MJ; Farrell K; Henderson B; Simon S; Raymond D; Elango S; Ortega RA; Shanker V; Swan M; Zhu CW; Ramdhani R; Walker RH; Tse W; Sano M; Pereira AC; Ahfeldt T; Goate AM; Bressman S; Crary JF; de Witte L; Frucht S; Saunders-Pullman R; Raj T
    Nat Aging; 2021 Sep; 1(9):850-863. PubMed ID: 35005630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic profiles in Parkinson's disease.
    Kurvits L; Lättekivi F; Reimann E; Kadastik-Eerme L; Kasterpalu KM; Kõks S; Taba P; Planken A
    Exp Biol Med (Maywood); 2021 Mar; 246(5):584-595. PubMed ID: 33148011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition.
    Konstantin Nissen S; Farmen K; Carstensen M; Schulte C; Goldeck D; Brockmann K; Romero-Ramos M
    Brain Behav Immun; 2022 Mar; 101():182-193. PubMed ID: 35026420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looking beyond the brain to improve the pathogenic understanding of Parkinson's disease: implications of whole transcriptome profiling of Patients' skin.
    Planken A; Kurvits L; Reimann E; Kadastik-Eerme L; Kingo K; Kõks S; Taba P
    BMC Neurol; 2017 Jan; 17(1):6. PubMed ID: 28068941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human glioblastoma-associated microglia/monocytes express a distinct RNA profile compared to human control and murine samples.
    Szulzewsky F; Arora S; de Witte L; Ulas T; Markovic D; Schultze JL; Holland EC; Synowitz M; Wolf SA; Kettenmann H
    Glia; 2016 Aug; 64(8):1416-36. PubMed ID: 27312099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease.
    Abdelmoaty MM; Machhi J; Yeapuri P; Shahjin F; Kumar V; Olson KE; Mosley RL; Gendelman HE
    Clin Transl Med; 2022 Jul; 12(7):e958. PubMed ID: 35802825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease.
    Drouin-Ouellet J; St-Amour I; Saint-Pierre M; Lamontagne-Proulx J; Kriz J; Barker RA; Cicchetti F
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiling of human intermediate monocytes.
    Zawada AM; Zhang L; Emrich IE; Rogacev KS; Krezdorn N; Rotter B; Fliser D; Devaux Y; Ziegler-Heitbrock L; Heine GH
    Immunobiology; 2017 Mar; 222(3):587-596. PubMed ID: 27876379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential blood biomarkers for Parkinson's disease by gene expression and DNA methylation data integration analysis.
    Wang C; Chen L; Yang Y; Zhang M; Wong G
    Clin Epigenetics; 2019 Feb; 11(1):24. PubMed ID: 30744671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson's disease.
    Craig DW; Hutchins E; Violich I; Alsop E; Gibbs JR; Levy S; Robison M; Prasad N; Foroud T; Crawford KL; Toga AW; Whitsett TG; Kim S; Casey B; Reimer A; Hutten SJ; Frasier M; Kern F; Fehlman T; Keller A; Cookson MR; Van Keuren-Jensen K;
    Nat Aging; 2021 Aug; 1(8):734-747. PubMed ID: 37117765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Profiling Uncovers Human Hyalocytes as a Unique Innate Immune Cell Population.
    Boneva SK; Wolf J; Rosmus DD; Schlecht A; Prinz G; Laich Y; Boeck M; Zhang P; Hilgendorf I; Stahl A; Reinhard T; Bainbridge J; Schlunck G; Agostini H; Wieghofer P; Lange CAK
    Front Immunol; 2020; 11():567274. PubMed ID: 33042148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
    Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM
    Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease.
    Infante J; Prieto C; Sierra M; Sánchez-Juan P; González-Aramburu I; Sánchez-Quintana C; Berciano J; Combarros O; Sainz J
    Neurobiol Aging; 2016 Feb; 38():214.e1-214.e5. PubMed ID: 26675812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Long Noncoding RNA Expression Precedes the Course of Parkinson's Disease-a Preliminary Report.
    Kraus TFJ; Haider M; Spanner J; Steinmaurer M; Dietinger V; Kretzschmar HA
    Mol Neurobiol; 2017 May; 54(4):2869-2877. PubMed ID: 27021022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the search for genetic biomarkers of Parkinson's disease into the living brain.
    Benoit SM; Xu H; Schmid S; Alexandrova R; Kaur G; Thiruvahindrapuram B; Pereira SL; Jog M; Hebb MO
    Neurobiol Dis; 2020 Jul; 140():104872. PubMed ID: 32302674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential diagnostic biomarkers for Parkinson's disease.
    Jiang F; Wu Q; Sun S; Bi G; Guo L
    FEBS Open Bio; 2019 Aug; 9(8):1460-1468. PubMed ID: 31199560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins.
    Mamrut S; Avidan N; Truffault F; Staun-Ram E; Sharshar T; Eymard B; Frenkian M; Pitha J; de Baets M; Servais L; Berrih-Aknin S; Miller A
    J Autoimmun; 2017 Aug; 82():62-73. PubMed ID: 28549776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease.
    Botta-Orfila T; Sànchez-Pla A; Fernández M; Carmona F; Ezquerra M; Tolosa E
    Brain Res; 2012 Jul; 1466():152-7. PubMed ID: 22634372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.